Vivo Development Ltd. is a Clinical Research Organization specialized in phase I clinical development studies, including bioequivalence, pharmacokinetics, first-time in human studies (FIH), formulation comparisons, food-drug and drug-drug interactions, and metabolism studies. We are based in Shanghai and conduct our clinical studies in Chinese SFDA approved phase I units in Shanghai and other cities.

We aim to provide early clinical development services to clients with a full spectrum of registration needs, including ANDA with the US FDA, MA with the EMEA, PQ with the WHO, and new product registration with the Chinese SFDA.

More...